CHINARES PHARMA (03320): China Resources Sanjiu Medical & Pharmaceutical's net profit in the first three quarters was approximately 2.899 billion yuan, a decrease of 10.65% year-on-year.
China Resources Pharmaceutical Group (03320) announces that the operational total revenue of CR 2035 for the first three quarters of 2025 is approximately 219.86 million...
CHINARES PHARMA (03320) announced the performance of China Resources Sanjiu Medical & Pharmaceutical in the first three quarters of 2025. The total operating income was approximately 21.986 billion yuan, an increase of 11.38% year-on-year; net profit was about 2.899 billion yuan, a decrease of 10.65% year-on-year.
Related Articles
Overnight US stocks | The three major indices simultaneously hit historical highs, with the Dow closing above 47,000 points for the first time in history.
IBM can use AMD chips to run quantum error correction algorithms, and their stock prices are soaring to a historic high.
Hong Kong stocks rise as Beijing vows stronger tech self-reliance and domestic support
Overnight US stocks | The three major indices simultaneously hit historical highs, with the Dow closing above 47,000 points for the first time in history.
IBM can use AMD chips to run quantum error correction algorithms, and their stock prices are soaring to a historic high.
Hong Kong stocks rise as Beijing vows stronger tech self-reliance and domestic support
RECOMMEND
Why European Automakers Are Opposing Dutch Sanctions
20/10/2025
Domestic Commercial Rockets Enter Batch Launch Era: Behind the Scenes a Sixfold Cost Gap and Reusability as the Key Breakthrough
20/10/2025
Multiple Positive Catalysts Lift Tech Stocks; UBS Elevates China Tech to Most Attractive, Citing AI as Core Rationale
20/10/2025
